Literature DB >> 26827189

Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis.

Jianing Wang1, Qi Zhao1, Gaoya Wang1, Chunshu Yang2, Yong Xu1, Yujia Li1, Pingting Yang3.   

Abstract

OBJECTIVE: Although chemokines are critical elements for the selective attraction and activation of various leukocyte subsets in the inflammatory process, there are few findings concerning T helper (Th) 1 or Th2 chemokines in ankylosing spondylitis (AS). This study was designed to determine whether serum levels of chemokines that are preferentially chemotactic for Th1 (IFN-gamma-inducible protein-10, IP-10/CXCL10) and Th2 (thymus and activation regulated chemokine, TARC/CCL17) and (macrophage derived chemokine, MDC/CCL22) cells were elevated and whether they correlated with the clinical features in patients with AS.
METHODS: Forty-two patients with axial AS and 25 healthy controls were enrolled into the study. Serum levels of chemokines (IP-10, TARC and MDC) and cytokines (IFN-γ, TNF-α and IL-4) were examined using ELISA. The disease activity was evaluated by Ankylosing Spondylitis Disease Activity Score (ASDAS). Serum levels of IgG, IgA, IgM, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured.
RESULTS: Serum chemokine levels of IP-10, TARC and MDC were significantly higher in patients with AS than those in healthy controls. Serum cytokine levels of IFN-γ, TNF-α were also significantly increased, but the levels of IL-4 were not. Furthermore, IP-10 levels in AS patients correlated with ESP, CRP and ASDAS, while the levels of TARC and MDC did not correlate with these clinic indexes. Correlation analysis between the levels of chemokines and cytokines revealed a positive correlation between IP-10 and TNF-α. The levels of both Th1 and Th2 chemokines decreased under blockade of TNF-α.
CONCLUSION: Our results suggest that both a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, cooperatively play a role in the development of AS.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Biomarker; Chemoattractants; Disease activity index; TNF blockade

Mesh:

Substances:

Year:  2016        PMID: 26827189     DOI: 10.1016/j.cyto.2016.01.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  16 in total

1.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.

Authors:  Andrew D Cook; Ming-Chin Lee; Reem Saleh; Hsu-Wei Khiew; Anne D Christensen; Adrian Achuthan; Andrew J Fleetwood; Derek C Lacey; Julia E Smith; Irmgard Förster; John A Hamilton
Journal:  JCI Insight       Date:  2018-03-22

3.  Identification of pathways significantly associated with spondyloarthropathy/ankylosing spondylitis using the sub‑pathway method.

Authors:  Ming Ding; Ting-Jin Guan; Chuan-Yin Wei; Bo-Hua Chen
Journal:  Mol Med Rep       Date:  2018-08-17       Impact factor: 2.952

4.  Aspects of intradermal immunization with different adjuvants: The role of dendritic cells and Th1/Th2 response.

Authors:  Zrinka Oreskovic; Katerina Nechvatalova; Josef Krejci; Vladimir Kummer; Martin Faldyna
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

5.  Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis.

Authors:  Matheus Braga; Fernanda Formaggi Lara-Armi; Janisleya Silva Ferreira Neves; Marco Antônio Rocha-Loures; Mariana de Souza Terron-Monich; Larissa Danielle Bahls-Pinto; Quirino Alves de Lima Neto; Joana Maira Valentini Zacarias; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

6.  Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease.

Authors:  Sevgi Irtegun; Gulsum Pektanc; Zeynep M Akkurt; Mehtap Bozkurt; Fatih M Turkcu; Sevgi Kalkanli-Tas
Journal:  Mediators Inflamm       Date:  2016-06-30       Impact factor: 4.711

7.  Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis.

Authors:  Cristina F Rabelo; Talita Siara Almeida Baptista; Laura Esteves Petersen; Moisés Evandro Bauer; Mauro Waldemar Keiserman; Henrique Luiz Staub
Journal:  Open Access Rheumatol       Date:  2018-04-30

8.  Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine.

Authors:  Robert O Dillman; Gabriel I Nistor; Aleksandra J Poole
Journal:  Hum Vaccin Immunother       Date:  2019-11-15       Impact factor: 3.452

9.  GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis.

Authors:  Hui Shi; Liye Chen; Anna Ridley; Nancy Zaarour; India Brough; Cherilyn Caucci; Julia E Smith; Paul Bowness
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

10.  Ankylosing spondylitis: etiology, pathogenesis, and treatments.

Authors:  Xu Cao; Xisheng Weng; Wei Zhu; Xuxia He; Kaiyuan Cheng; Linjie Zhang; Di Chen; Xiao Wang; Guixing Qiu
Journal:  Bone Res       Date:  2019-08-05       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.